Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
ABSTRACT
SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. We systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in a large cohort of unexposed individuals as well as exposed family members and individuals with acute or convalescent COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative family members and individuals with a history of asymptomatic or mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits robust memory T cell responses akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 also in seronegative individuals.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
One sentence summary SARS-CoV-2 induces robust memory T cell responses in antibody-seronegative and antibody-seropositive individuals with asymptomatic or mild COVID-19.
Subject Area
- Biochemistry (11493)
- Bioengineering (8568)
- Bioinformatics (28730)
- Biophysics (14725)
- Cancer Biology (11850)
- Cell Biology (17059)
- Clinical Trials (138)
- Developmental Biology (9273)
- Ecology (13965)
- Epidemiology (2067)
- Evolutionary Biology (18064)
- Genetics (12105)
- Genomics (16553)
- Immunology (11653)
- Microbiology (27533)
- Molecular Biology (11322)
- Neuroscience (59843)
- Paleontology (446)
- Pathology (1839)
- Pharmacology and Toxicology (3169)
- Physiology (4853)
- Plant Biology (10221)
- Synthetic Biology (2827)
- Systems Biology (7271)
- Zoology (1605)